2025-08-14 - Analysis Report
Okay, here's a report analyzing Colgate-Palmolive (CL) based on the data you provided.

## Colgate-Palmolive Co (CL) Stock Analysis

**Colgate-Palmolive Co (CL) is a global consumer products company focusing on oral care, personal care, home care, and pet nutrition.**

### 1. Performance vs. S&P 500 (VOO)

*   **CL Cumulative Return:** 12.17%
*   **VOO Cumulative Return:** 86.23%
*   **Absolute Divergence:** -70.9%
*   **Relative Divergence:** 0.0 (This indicates CL is at the lowest end of its historical divergence range compared to VOO)

**Analysis:** CL has significantly underperformed the S&P 500 over the period examined.  The relative divergence indicates that CL's underperformance is at the most extreme end of its historical range.

**Alpha/Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
|------------|--------|--------|---------|--------|--------|
| 2015-2017  | 3.0%   | 0.0%   | 0.0%    | -0.2   | 61.0   |
| 2016-2018  | -16.0%  | 65.2%  | -11.0%  | -0.1   | 48.1   |
| 2017-2019  | -2.0%  | 65.2%  | -25.0%  | -0.0   | 55.6   |
| 2018-2020  | 20.0%  | 65.2%  | -7.0%   | 0.0    | 69.1   |
| 2019-2021  | 30.0%  | 58.6%  | -19.0%  | 0.2    | 69.0   |
| 2020-2022  | 8.0%   | 69.0%  | 2.0%    | 0.2    | 63.7   |
| 2021-2023  | 7.0%   | 69.0%  | -13.0%  | 0.9    | 64.4   |
| 2022-2024  | 14.0%  | 69.0%  | -13.0%  | 0.9    | 73.5   |
| 2023-2025  | 2.0%   | 70.6%  | -49.0%  | 0.3    | 69.8   |

*   **CAGR (Compound Annual Growth Rate):** Varies significantly, showing periods of growth and decline.
*   **MDD (Maximum Drawdown):** High MDD values suggest significant potential losses in some periods.
*   **Alpha:** Generally negative alpha values indicate underperformance relative to the benchmark.
*   **Beta:** Low beta values suggest CL is less volatile than the market.  In recent periods (2021-2024), beta has increased, suggesting higher correlation with the market.
*   **Cap(B):** Market capitalization fluctuating between 48.1B to 73.5B

### 2. Recent Price Action

*   **Current Price:** 86.34
*   **Previous Close:** 84.97
*   **Change:** 1.61
*   **5-day Moving Average:** 85.03
*   **20-day Moving Average:** 85.86
*   **60-day Moving Average:** 89.04

**Analysis:**  The price increased significantly from the previous close. The current price is above the 5-day and 20-day moving averages but below the 60-day moving average. This suggests a short-term uptrend but potentially facing resistance at the 60-day level.

### 3. Market Risk Indicators & Signals

*   **MRI (Market Risk Indicator):** 0.32 (Low Risk)
*   **RSI (Relative Strength Index):** 39.42 (Approaching Oversold)
*   **PPO (Percentage Price Oscillator):** 0.199
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (1183 shares - Safe (OverSold Boost) - MRI:0.32)
*   **Delta_Previous_Relative_Divergence:** -4.5 (Negative, indicating short-term decline)
*   **Expected Return:** -2289.6%

**Analysis:**

*   The low MRI suggests a low-risk environment, but keep in mind this is a single indicator.
*   The RSI approaching 40 indicates the stock is nearing an oversold condition, which might signal a potential buying opportunity.
*   The negative change in relative divergence reinforces the recent underperformance.
*   The "Hybrid Signal" suggests a buying opportunity based on the oversold condition and low market risk, but the extremely negative expected return is concerning and warrants further investigation. Such a large negative number is likely anomalous and suggests an error in calculation or data input.  This should NOT be taken at face value.

### 4. Recent News & Significant Events

*   **2025-08-11:** Major business developments, regulatory changes, or market events.
*   **2025-08-13:** Analyst discussions regarding performance, industry trends, and global economic factors.
*   **2025-08-12:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-08-14:** Market experts highlighting risks and opportunities.

**Analysis:** The news suggests the stock is experiencing volatility and is subject to market and economic pressures. Keep an eye on specific news releases to understand the drivers of these events.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-08-01 | 0.92  | 5.11 B$    |
| 2025-04-25 | 0.85  | 4.91 B$    |
| 2024-10-25 | 0.90  | 5.03 B$    |
| 2024-07-26 | 0.89  | 5.06 B$    |
| 2025-08-01 | 0.89  | 5.06 B$    |

**Analysis:** The EPS (Earnings Per Share) and Revenue show a relatively stable trend. There is a slight increase in EPS recently.

### 6. Financial Information:

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $5.11B  | 60.06%        |
| 2025-03-31 | $4.91B  | 60.82%        |
| 2024-12-31 | $4.95B  | 60.30%        |
| 2024-09-30 | $5.03B  | 61.08%        |
| 2024-06-30 | $5.06B  | 60.62%        |

**Capital and Profitability:**

| Quarter    | Equity | ROE       |
|------------|---------|-----------|
| 2025-06-30 | $0.70B  | 105.84%   |
| 2025-03-31 | $0.36B  | 190.08%   |
| 2024-12-31 | $0.21B  | 348.58%   |
| 2024-09-30 | $0.43B  | 169.43%   |
| 2024-06-30 | $0.12B  | 594.31%   |

**Analysis:**

*   **Revenue:** Relatively stable revenue figures.
*   **Profit Margin:** Consistently high profit margins, indicating strong pricing power.
*   **Equity:** Fluctuating equity values.
*   **ROE (Return on Equity):** Exceptionally high ROE values, particularly in the earlier quarters. This could be due to a combination of factors, including share buybacks or one-time gains, and requires further investigation to understand its sustainability.

### 7. Overall Summary

Colgate-Palmolive (CL) is currently underperforming the S&P 500 significantly, and recent news points to volatility.  However, the RSI is approaching oversold levels, and the MRI indicates a low-risk environment.  Earnings and revenue show stability, and profit margins are consistently high. The ROE is exceptionally high, but its sustainability needs to be verified.

**Recommendations:**

*   **Due Diligence:** Investigate the reasons for the large negative expected return, recent business developments, regulatory changes, and the drivers behind the fluctuating equity and high ROE.
*   **Monitor News:** Keep a close watch on news releases and analyst reports for CL to understand the factors affecting the stock's performance.
*   **Consider a Value Play:**  If you believe CL's underperformance is temporary and the company's fundamentals remain strong, the oversold conditions might present a long-term value opportunity. However, be aware of the risks.
